skip to main content
Idioma:
Primo Advanced Search
Primo Advanced Search Query Term
Primo Advanced Search Query Term
Primo Advanced Search Query Term
Primo Advanced Search prefilters
Busca Simples
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Is there a positive effect of participation on a clinical trial for patients with advanced non-small cell lung cancer?
Is there a positive effect of participation on a clinical trial for patients with advanced non-small cell lung cancer?
Material Type:
Artigo 		Adicionar ao Meu Espaço

Is there a positive effect of participation on a clinical trial for patients with advanced non-small cell lung cancer?

Rajappa, S ; Gundeti, S ; Uppalapati, S ; Jiwatani, S ; Abhyankar, A ; Pal, C ; Digumarti, R

Indian journal of cancer, 2008-10, Vol.45 (4), p.158-163 [Periódico revisado por pares]

India: Medknow Publications & Media Pvt. Ltd

Texto completo disponível

Citações Citado por
2
Is there a positive effect of participation on a clinical trial for patients with advanced non-small cell lung cancer?
Is there a positive effect of participation on a clinical trial for patients with advanced non-small cell lung cancer?
Material Type:
Artigo 		Adicionar ao Meu Espaço

Is there a positive effect of participation on a clinical trial for patients with advanced non-small cell lung cancer?

Rajappa, S ; Gundeti, S ; Uppalapati, S ; Jiwatani, S ; Abhyankar, A ; Pal, C ; Digumarti, R

Indian journal of cancer, 2009-03, Vol.45 (4) [Periódico revisado por pares]

India: Medknow Publications on behalf of Indian Cancer Society

Texto completo disponível

Citações Citado por
3
Is there a positive effect of participation on a clinical trial for patients with advanced non-small cell lung cancer#x003F
Is there a positive effect of participation on a clinical trial for patients with advanced non-small cell lung cancer#x003F
Material Type:
Artigo 		Adicionar ao Meu Espaço

Is there a positive effect of participation on a clinical trial for patients with advanced non-small cell lung cancer#x003F

Rajappa, S ; Jiwatani, S ; Pal, C ; Gundeti, S ; Digumarti, R ; Abhyankar, A ; Uppalapati, S

Indian journal of cancer, 2008-10, Vol.45 (4), p.158 [Periódico revisado por pares]

Medknow Publications and Media Pvt. Ltd

Texto completo disponível

Citações Citado por
4
Safety, Tolerability, and Pharmacokinetics of a Capsule Formulation of DRF-1042, a Novel Camptothecin Analog, in Refractory Cancer Patients in a Bridging Phase I Study
Safety, Tolerability, and Pharmacokinetics of a Capsule Formulation of DRF-1042, a Novel Camptothecin Analog, in Refractory Cancer Patients in a Bridging Phase I Study
Material Type:
Artigo 		Adicionar ao Meu Espaço

Safety, Tolerability, and Pharmacokinetics of a Capsule Formulation of DRF-1042, a Novel Camptothecin Analog, in Refractory Cancer Patients in a Bridging Phase I Study

Chatterjee, Arani ; Digumarti, Raghunadharao ; Katneni, Kasiram ; Upreti, Vijay V. ; Mamidi, Rao N. V. S. ; Mullangi, Ramesh ; Surath, Anjna ; Srinivas, Maddali L. ; Uppalapati, Srihari ; Jiwatani, Sangeeta ; Srinivas, Nuggehally R.

Journal of clinical pharmacology, 2005-04, Vol.45 (4), p.453-460 [Periódico revisado por pares]

Oxford, UK: Blackwell Publishing Ltd

Texto completo disponível

Citações Citado por
5
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of an Orally Active Novel Camptothecin Analog, DRF-1042, in Refractory Cancer Patients in a Phase I Dose Escalation Study
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of an Orally Active Novel Camptothecin Analog, DRF-1042, in Refractory Cancer Patients in a Phase I Dose Escalation Study
Material Type:
Artigo 		Adicionar ao Meu Espaço

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of an Orally Active Novel Camptothecin Analog, DRF-1042, in Refractory Cancer Patients in a Phase I Dose Escalation Study

Chatterjee, Arani ; Digumarti, Raghunadharao ; Mamidi, Rao N. V. S. ; Katneni, Kasiram ; Upreti, Vijay V. ; Surath, Anjna ; Srinivas, Maddali L. ; Uppalapati, Srihari ; Jiwatani, Sangeeta ; Subramaniam, Swaminathan ; Srinivas, Nuggehally R.

Journal of clinical pharmacology, 2004-07, Vol.44 (7), p.723-736 [Periódico revisado por pares]

Oxford, UK: Blackwell Publishing Ltd

Texto completo disponível

Citações Citado por
6
Role of the MDM2 Promoter Polymorphism (-309T>G) in Acute Myeloid Leukemia Development
Role of the MDM2 Promoter Polymorphism (-309T>G) in Acute Myeloid Leukemia Development
Material Type:
Artigo 		Adicionar ao Meu Espaço

Role of the MDM2 Promoter Polymorphism (-309T>G) in Acute Myeloid Leukemia Development

Cingeetham, Anuradha ; Vuree, Sugunakar ; Jiwatani, Sangeeta ; Kagita, Sailaja ; Dunna, Nageswara Rao ; Meka, Phanni Bhushann ; Gorre, Manjula ; Annamaneni, Sandhya ; Digumarti, Raghunadharao ; Sinha, Sudha ; Satti, Vishnupriya

Asian Pacific journal of cancer prevention : APJCP, 2015, Vol.16 (7), p.2707-2712 [Periódico revisado por pares]

Texto completo disponível

Citações Citado por

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Data de Publicação 

De até
Refinar
  1. Antes de2004  (1)
  2. 2004Até2004  (1)
  3. 2005Até2007  (1)
  4. 2008Até2009  (3)
  5. Após 2009  (1)
  6. Mais opções open sub menu

Idioma 

  1. Inglês  (4)
  2. Coreano  (1)
  3. Mais opções open sub menu

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.